| scholarly article | Q13442814 |
| P2093 | author name string | Yang Xia | |
| Chen Liu | |||
| Patrick S Daugherty | |||
| Rodney E Kellems | |||
| Nicholas F Parchim | |||
| Serra E Elliott | |||
| Alex R Soffici | |||
| P2860 | cites work | Soluble endoglin contributes to the pathogenesis of preeclampsia | Q28244053 |
| Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort | Q28741729 | ||
| Analysis of gene control signals by DNA fusion and cloning in Escherichia coli | Q29615300 | ||
| Directed evolution of a biterminal bacterial display scaffold enhances the display of diverse peptides | Q33334749 | ||
| Quantitative specificity-based display library screening identifies determinants of antibody-epitope binding specificity | Q33483445 | ||
| Bacterial display enables efficient and quantitative peptide affinity maturation | Q33515720 | ||
| The detrimental role of angiotensin receptor agonistic autoantibodies in intrauterine growth restriction seen in preeclampsia | Q33591058 | ||
| Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with disease severity | Q33748680 | ||
| Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor | Q33848380 | ||
| Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia | Q33863973 | ||
| Autoantibody-mediated complement C3a receptor activation contributes to the pathogenesis of preeclampsia | Q34040357 | ||
| Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance | Q34448410 | ||
| Association between the presence of autoantibodies against adrenoreceptors and severe pre-eclampsia: a pilot study | Q34618522 | ||
| Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice | Q35701236 | ||
| Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia | Q35871381 | ||
| Apoptosis signaling is altered in CD4⁺CD25⁺FoxP3⁺ T regulatory lymphocytes in pre-eclampsia. | Q36096862 | ||
| Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats | Q37436219 | ||
| Association of anticardiolipin antibodies with preeclampsia: a systematic review and meta-analysis | Q37811769 | ||
| First trimester screening of serum soluble fms-like tyrosine kinase-1 and placental growth factor predicting hypertensive disorders of pregnancy | Q40806992 | ||
| Tick-borne encephalitis virus-neutralizing antibodies in different immunoglobulin preparations | Q42559156 | ||
| Elevation of angiotensin-II type-1-receptor autoantibodies titer in primary aldosteronism as a result of aldosterone-producing adenoma. | Q44117739 | ||
| Autoantibodies against AT1-receptor and alpha1-adrenergic receptor in patients with hypertension | Q44162378 | ||
| Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection | Q45259438 | ||
| Circulating angiogenic factors and the risk of preeclampsia | Q47217679 | ||
| Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study. | Q54782424 | ||
| Trophoblasts Reduce the Vascular Smooth Muscle Cell Proatherogenic Response | Q56981910 | ||
| Angiogenic factors as diagnostic tests for preeclampsia: a performance comparison between two commercial immunoassays | Q58623865 | ||
| CD19 + CD5 + Cells as Indicators of Preeclampsia | Q59906564 | ||
| Anti-Prothrombin Antibodies are Associated with Adverse Pregnancy Outcome | Q61851336 | ||
| Contemporary concepts of the pathogenesis and management of preeclampsia | Q74331806 | ||
| Biomarker for hypertension-preeclampsia: are we close yet? | Q80586027 | ||
| Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature | Q81423834 | ||
| Pre-eclampsia | Q81446389 | ||
| PP13 as a marker of pre-eclampsia: A two platform comparison study | Q83269636 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| pre-eclampsia | Q61335 | ||
| P304 | page(s) | 1086-1093 | |
| P577 | publication date | 2014-01-20 | |
| P1433 | published in | Hypertension | Q5958695 |
| P1476 | title | Characterization of antibody specificities associated with preeclampsia | |
| P478 | volume | 63 |
| Q50182939 | APOL1-G0 or APOL1-G2 Transgenic Models Develop Preeclampsia but Not Kidney Disease |
| Q36836373 | Elevated Transglutaminase Activity Triggers Angiotensin Receptor Activating Autoantibody Production and Pathophysiology of Preeclampsia |
| Q60194447 | Fetal-Not Maternal-APOL1 Genotype Associated with Risk for Preeclampsia in Those with African Ancestry |
| Q36584747 | Preeclampsia and Pregnancy-Related Hypertensive Disorders |
| Q92646104 | Roles and possible mechanisms of autoantibodies against the angiotensin AT1 receptor in vascular calcification of rats |
| Q26997997 | Serology in the 21st century: the molecular-level analysis of the serum antibody repertoire |
| Q37240779 | Transglutaminase is a Critical Link Between Inflammation and Hypertension |
Search more.